You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
|
|---|---|
| Published in |
Frontiers in Pharmacology, July 2019
|
| DOI | 10.3389/fphar.2019.00738 |
| Pubmed ID | |
| Authors |
Claudia Balducci, Gianluigi Forloni |
X Demographics
The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 8 | 22% |
| United States | 2 | 5% |
| United Kingdom | 1 | 3% |
| Congo, The Democratic Republic of the | 1 | 3% |
| Papua New Guinea | 1 | 3% |
| Uruguay | 1 | 3% |
| Belgium | 1 | 3% |
| Colombia | 1 | 3% |
| Austria | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 19 | 51% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 30 | 81% |
| Practitioners (doctors, other healthcare professionals) | 4 | 11% |
| Scientists | 3 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 83 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 13 | 16% |
| Researcher | 9 | 11% |
| Student > Master | 8 | 10% |
| Student > Bachelor | 8 | 10% |
| Unspecified | 7 | 8% |
| Other | 18 | 22% |
| Unknown | 20 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 16 | 19% |
| Biochemistry, Genetics and Molecular Biology | 10 | 12% |
| Unspecified | 7 | 8% |
| Medicine and Dentistry | 5 | 6% |
| Agricultural and Biological Sciences | 4 | 5% |
| Other | 16 | 19% |
| Unknown | 25 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2024.
All research outputs
#1,515,123
of 25,800,372 outputs
Outputs from Frontiers in Pharmacology
#584
of 20,019 outputs
Outputs of similar age
#31,814
of 363,820 outputs
Outputs of similar age from Frontiers in Pharmacology
#16
of 336 outputs
Altmetric has tracked 25,800,372 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,019 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,820 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 336 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.